News und Analysen
EQS-News: Aurubis AG: Annual General Meeting approves record dividend; Growth course affirmed
EQS-News: Aurubis AG: Annual General Meeting approves record dividend; Growth course affirmed
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-Adhoc: CTS Eventim: Record-breaking performance in 2022 with substantial revenue and profit growth
EQS-Adhoc: CTS Eventim: Record-breaking performance in 2022 with substantial revenue and profit growth
EQS-News: Commerzbank reports highest net profit in more than ten years thanks to strong revenue performance – positive outlook for 2023
EQS-News: Commerzbank reports highest net profit in more than ten years thanks to strong revenue performance – positive outlook for 2023
EQS-News: HELLA GmbH & Co. KGaA: Preliminary figures and company outlook published: HELLA expects record sales and further improved profitability for 2023
EQS-News: HELLA GmbH & Co. KGaA: Preliminary figures and company outlook published: HELLA expects record sales and further improved profitability for 2023
EQS-News: Aurubis AG: Expanding capacity: Aurubis invests € 120 million in expanding the tankhouse in Pirdop
EQS-News: Aurubis AG: Expanding capacity: Aurubis invests € 120 million in expanding the tankhouse in Pirdop
EQS-News: Commerzbank Supervisory Board intends to appoint Jens Weidmann as new Chairman
EQS-News: Commerzbank Supervisory Board intends to appoint Jens Weidmann as new Chairman
EQS-News: Stabilus SE: Annual General Meeting approves dividend of €1.75 per share and re-election of four Supervisory Board members
EQS-News: Stabilus SE: Annual General Meeting approves dividend of €1.75 per share and re-election of four Supervisory Board members
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Commerzbank plans to propose a dividend of €0.20 per share for financial year 2022
Commerzbank plans to propose a dividend of €0.20 per share for financial year 2022
EQS-Adhoc: Commerzbank plans to propose a dividend of €0.20 per share for financial year 2022
EQS-Adhoc: Commerzbank plans to propose a dividend of €0.20 per share for financial year 2022
EQS-News: ENCAVIS AG significantly exceeds all KPIs of the guidance for fiscal year 2022 with its prelim. unaudited results / Revenue and oper. EBITDA already exceed the targets of the growth strategy FF 2025
EQS-News: ENCAVIS AG significantly exceeds all KPIs of the guidance for fiscal year 2022 with its prelim. unaudited results / Revenue and oper. EBITDA already exceed the targets of the growth strategy FF 2025
EQS-Adhoc: ENCAVIS AG: All KPIs of the preliminary and unaudited results for the full-year 2022 are significantly above guidance of FY 2022
EQS-Adhoc: ENCAVIS AG: All KPIs of the preliminary and unaudited results for the full-year 2022 are significantly above guidance of FY 2022
EQS-News: Delivery Hero repurchases outstanding convertible bonds due in 2024 and 2025
EQS-News: Delivery Hero repurchases outstanding convertible bonds due in 2024 and 2025
EQS-Adhoc: United Internet AG: Resolutions to reduce capital by cancelling own shares and to make a public share buyback offer
EQS-Adhoc: United Internet AG: Resolutions to reduce capital by cancelling own shares and to make a public share buyback offer
EQS-Adhoc: United Internet AG: Resolutions to reduce capital by cancelling own shares and to make a public share buyback offer
EQS-Adhoc: United Internet AG: Resolutions to reduce capital by cancelling own shares and to make a public share buyback offer
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Nemetschek Group Achieves Its Revenue and Profitability Targets in the Fiscal Year 2022
EQS-News: Nemetschek Group Achieves Its Revenue and Profitability Targets in the Fiscal Year 2022
EQS-News: Nemetschek Group Achieves Its Revenue and Profitability Targets in the Fiscal Year 2022
EQS-News: Nemetschek Group Achieves Its Revenue and Profitability Targets in the Fiscal Year 2022
TUI AG: INTERIM REPORT Q1 2023 1 OCTOBER 2022 – 31 DECEMBER 2022
TUI AG: INTERIM REPORT Q1 2023 1 OCTOBER 2022 – 31 DECEMBER 2022
EQS-News: Delivery Hero successfully places 3.25% EUR 1,000 million convertible bonds due in 2030
EQS-News: Delivery Hero successfully places 3.25% EUR 1,000 million convertible bonds due in 2030
EQS-Adhoc: Delivery Hero SE to issue convertible bonds and launch a subsequent tender offer for outstanding convertible bonds
EQS-Adhoc: Delivery Hero SE to issue convertible bonds and launch a subsequent tender offer for outstanding convertible bonds
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Nordson Corporation Appoints Sarah Siddiqui as Chief Human Resources Officer
Nordson Corporation (NASDAQ: NDSN) announced that Sarah Siddiqui has been named executive vice president and chief human resources officer, effective February 20, 2023. Ms. Siddiqui succeeds Shelly
